Why Is Life Science Focused Bruker Stock Trading Higher On Friday?

Bruker Corporation (NASDAQ:BRKR) reported preliminary revenue Friday for the first quarter that ended March 31, 2025, of $795 million to $800 million compared to a consensus of $758.85 million.

The company’s sales reflect around 10-11% year-over-year increase from $721.70 million.

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research and industrial and applied analysis.

This estimated range implies a reported revenue growth of approximately 10% year over year, with low double-digit percentage constant exchange rate revenue growth.

Bruker estimates adjusted organic revenue growth in the first quarter to ...

https://www.benzinga.com/general/health-care/25/04/44763100/why-is-life-science-focused-bruker-stock-trading-higher-on-friday